Suppr超能文献

基于人群的病例对照研究中男性型秃发与前列腺癌风险。

Male pattern baldness and prostate cancer risk in a population-based case-control study.

机构信息

Department of Urology, University of Washington School of Medicine, Seattle, WA, United States.

出版信息

Cancer Epidemiol. 2010 Apr;34(2):131-5. doi: 10.1016/j.canep.2010.02.003. Epub 2010 Mar 4.

Abstract

PURPOSE

Male pattern baldness (MPB) and prostate cancer (PCa) share commonality as prevalent, heritable and androgen-related conditions. Studies exploring the relationship between the two conditions have been inconclusive. Using a population-based, case-control study of PCa, we explore the relationship between early-onset MPB and PCa risk.

METHODS

Cases were men aged 35-74 diagnosed with PCa between 2002 and 2005 in King County, Washington. Controls were frequency matched by age and identified by random digit dialing. Hair pattern at age 30 and at 1 year prior to diagnosis (cases) or reference date (controls) was determined using showcards. PCa risk associated with balding was assessed with logistic regression.

RESULTS

Data from 999 cases of PCa and 942 controls were analyzed. Hair loss at age 30 was more common in controls (25.2%) than cases (19.8%, p=0.005), and those with hair loss at age 30 had a 29% relative risk reduction for PCa (OR 0.71, 95% CI 0.56-0.91). No risk reduction was seen for men only reporting hair loss at referent age (OR 0.90, 95% CI 0.73-1.12). In men aged >60 at referent date, the risk reduction was greater for men with hair loss at age 30 from both the top of head and forehead (OR 0.55, 95% CI 0.33-0.93).

CONCLUSION

Early-onset MPB was associated with a reduced relative risk of PCa in this population-based study. Further research into a possible mechanistic link between these prevalent and androgen-related conditions is warranted.

摘要

目的

男性型秃发(MPB)和前列腺癌(PCa)具有共同的特征,即普遍存在、遗传性和雄激素相关。探索这两种疾病之间关系的研究尚无定论。本研究使用基于人群的 PCa 病例对照研究,探索早发性 MPB 与 PCa 风险之间的关系。

方法

病例为 2002 年至 2005 年期间在华盛顿金县诊断为 PCa 的 35-74 岁男性。对照通过年龄频数匹配,并通过随机数字拨号确定。通过展示卡确定 30 岁时和诊断(病例)或参考日期(对照)前 1 年的发式。使用逻辑回归评估秃发与 PCa 风险的相关性。

结果

分析了 999 例 PCa 病例和 942 例对照的数据。对照组(25.2%)中 30 岁时脱发的比例高于病例组(19.8%,p=0.005),30 岁时脱发的患者 PCa 的相对风险降低了 29%(OR 0.71,95%CI 0.56-0.91)。仅在参考年龄报告脱发的男性未观察到风险降低(OR 0.90,95%CI 0.73-1.12)。在参考日期年龄 >60 岁的男性中,30 岁时从头顶和前额脱发的男性风险降低更大(OR 0.55,95%CI 0.33-0.93)。

结论

在这项基于人群的研究中,早发性 MPB 与 PCa 的相对风险降低相关。需要进一步研究这两种普遍存在且与雄激素相关的疾病之间可能存在的机制联系。

相似文献

1
Male pattern baldness and prostate cancer risk in a population-based case-control study.
Cancer Epidemiol. 2010 Apr;34(2):131-5. doi: 10.1016/j.canep.2010.02.003. Epub 2010 Mar 4.
2
Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer.
Cancer Epidemiol Biomarkers Prev. 2024 Jan 9;33(1):143-150. doi: 10.1158/1055-9965.EPI-23-0908.
3
Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study.
Cancer Causes Control. 2018 Jan;29(1):93-102. doi: 10.1007/s10552-017-0981-0. Epub 2017 Nov 14.
4
Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study.
Cancer Causes Control. 2009 Nov;20(9):1617-22. doi: 10.1007/s10552-009-9407-y. Epub 2009 Aug 4.
6
Early onset baldness and prostate cancer risk.
Cancer Epidemiol Biomarkers Prev. 2000 Mar;9(3):325-8.
7
Male pattern baldness and the risk of prostate cancer.
Ann Oncol. 2011 Aug;22(8):1824-7. doi: 10.1093/annonc/mdq695. Epub 2011 Feb 15.
8
Is digoxin use for cardiovascular disease associated with risk of prostate cancer?
Prostate. 2014 Jan;74(1):97-102. doi: 10.1002/pros.22733. Epub 2013 Sep 21.

引用本文的文献

1
Factors associated with early-onset androgenetic alopecia: A scoping review.
PLoS One. 2024 Mar 7;19(3):e0299212. doi: 10.1371/journal.pone.0299212. eCollection 2024.
3
Baldness and Risk of Prostate Cancer in the Health Professionals Follow-up Study.
Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1229-1236. doi: 10.1158/1055-9965.EPI-19-1236. Epub 2020 Apr 10.
4
Male pattern baldness and incidence of prostate cancer: A systematic review and meta-analysis.
Medicine (Baltimore). 2018 Jul;97(28):e11379. doi: 10.1097/MD.0000000000011379.
6
The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy.
Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E424-E427. doi: 10.5489/cuaj.3813. Epub 2016 Dec 12.

本文引用的文献

1
Susceptibility variants for male-pattern baldness on chromosome 20p11.
Nat Genet. 2008 Nov;40(11):1279-81. doi: 10.1038/ng.228. Epub 2008 Oct 12.
2
Male-pattern baldness susceptibility locus at 20p11.
Nat Genet. 2008 Nov;40(11):1282-4. doi: 10.1038/ng.255. Epub 2008 Oct 12.
3
Statin use and risk of prostate cancer: results from a population-based epidemiologic study.
Am J Epidemiol. 2008 Aug 1;168(3):250-60. doi: 10.1093/aje/kwn141. Epub 2008 Jun 12.
4
5α-Reductase Isozymes in the Prostate.
J Med Sci. 2005;25(1):1-12.
5
Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
Br J Dermatol. 2008 May;158(5):1121-4. doi: 10.1111/j.1365-2133.2008.08509.x. Epub 2008 Mar 20.
6
Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
J Natl Cancer Inst. 2008 Feb 6;100(3):170-83. doi: 10.1093/jnci/djm323. Epub 2008 Jan 29.
8
The role of prevalence in the diagnosis of prostate cancer.
Cancer Control. 2006 Jul;13(3):158-68. doi: 10.1177/107327480601300302.
10
The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):993-6. doi: 10.1158/1055-9965.EPI-04-0778.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验